Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine/Rituximab Followed by Venetoclax and Rituximab for Frontline CLL
NCT03609593Phase 2Completed
- Start
- Nov 2018
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of venetoclax in chronic lymphocytic leukemia (CLL). Started Nov 2018; status: completed.
02
Drugs
venetoclax
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT03609593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03609593.